Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02362828
Other study ID # EPiMAP Obstetrics
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 2016
Est. completion date March 31, 2019

Study information

Verified date December 2018
Source European Society of Anaesthesiology
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aims of EPiMAP Obstetrics are: - to identify risk factors for failure of epidural blood patch in the obstetric population for management of post dural puncture headache. - to describe European practices in the management of accidental dural puncture in the Obstetric population.


Description:

The primary aim of this prospective, international audit of practice is to identify risk factors for failure of epidural blood patch (EBP) in the Obstetric population after accidental dural puncture (ADP) with an epidural needle. Other aims are to describe the epidemiology, management principles, side effects and complications of ADP and longer-term effects of ADP on patients undergoing Obstetric anaesthesia and analgesia. Expectation is that this audit of practice will provide important information in understanding the reasons for failure of EBP and subsequently to better manage parturients affected by this debilitating complication. Postdural puncture headache (PDPH) is the most common serious complication of accidental dural puncture (ADP), and feared by every Anaesthesiologist. It is associated with significant peri-partum maternal distress, and poor bonding with the baby, which in turn leads to physical disability for the mother and psychological and social implications for the whole family. It is estimated that about 10,000 parturients in Europe may have an accidental dural puncture (ADP) each year. Attitudes and practices in the management of ADP are based on small studies, and sometimes driven by experience rather than evidence. Although several methods have been described in the literature to treat PDPH, one common method used is an epidural blood patch (EBP). This is believed to be successful in about 60-80% of parturients on the first attempt, but results from most studies are based on a small numbers of patients. The reasons and predisposing factors for success and failure of different management strategies, specifically EBP, therefore needs to be investigated and described. Large observational studies on post-dural puncture headache in the Obstetric population are singularly absent from the literature.


Recruitment information / eligibility

Status Completed
Enrollment 1110
Est. completion date March 31, 2019
Est. primary completion date December 31, 2018
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - All women = 18 years old, who develop classical symptoms of post-dural puncture headache after epidural anaesthesia for labour or for caesarean section. Exclusion Criteria: - Post-dural puncture headache following deliberate dural puncture with a spinal needle in women where there was no observed accidental dural puncture with an epidural needle.

Study Design


Locations

Country Name City State
Sweden Karolinska Hospital Stockholm

Sponsors (1)

Lead Sponsor Collaborator
European Society of Anaesthesiology

Country where clinical trial is conducted

Sweden, 

References & Publications (1)

Gupta A, von Heymann C, Magnuson A, Alahuhta S, Fernando R, Van de Velde M, Mercier FJ, Schyns-van den Berg AMJV; EPiMAP collaborators. Management practices for postdural puncture headache in obstetrics: a prospective, international, cohort study. Br J An — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary To examine the risk factors for failed epidural blood patch (EBP) following post-dural puncture headache To examine the risk factors for failed epidural blood patch (EBP) following post-dural puncture headache, in the obstetric population. Failure would be defined as lack of reduction in pain intensity by at least 50% at 24 h after application of EBP, compared to worst pain before EBP or a visual analogue pain score (VAS pain) of > 3 at 24 h. 24 h after application of Epidural blood patch
Secondary European practices in the management of Post Dural Puncture Headache (PDPH) 24 h after application of Epidural blood patch
Secondary Incidence of significant Post Dural Puncture Headache (PDPH) and treatment failure in different countries in Europe 24 h after application of Epidural blood patch
Secondary Timing of the procedure (after diagnosis of PDPH) and the volume of blood injected in relation to success or failure 24 h after application of Epidural blood patch
Secondary Complications and side effects of Epidural blood patch (EBP) Complications include : Chronic headache and backache, neurological injuries, audiological or visual other chronic impairments 24 h after application of Epidural blood patch
Secondary Variation in practices for management of Accidental Dural Puncture (ADP) in different European countries 24 h after application of Epidural blood patch
See also
  Status Clinical Trial Phase
Completed NCT04091321 - Association Between Chronic Headache and Back Pain With Childbirth
Recruiting NCT05202574 - Comparing the Effects of Ondansetron Versus Dexamethasone on the Incidence of Post-dural Puncture Headache (PDPH) , Nausea and Vomiting After Spinal Anaesthesia of Parturients Undergoing Caesarean Section Phase 2
Terminated NCT02813655 - Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE) Phase 2
Completed NCT02522013 - Aminophylline for Patients With Post-Dural Puncture Headache Phase 3
Completed NCT05301387 - The Effect of Ganglion Sphenopalatine Block (GSP-block) Follow-Up
Recruiting NCT05637645 - Different Approaches of Spinal Anesthesia in Patients Undergoing Cesarean Section N/A
Recruiting NCT05116930 - Neostigmine and Glycopyrrolate for the Treatment of Headache After Dural Puncture Phase 2
Terminated NCT03430531 - Effectiveness of Sphenopalatine Ganglion Block for Post-Dural Puncture Headache Phase 2
Completed NCT04401878 - SGB in Management of Patients With PDPH Using TCD N/A
Completed NCT04327726 - Effectiveness of Nebulized Dexmedetomidine for Treatment of Obstetric Post-Dural Puncture Headache N/A
Completed NCT03475784 - Two Fluid Strategies for Prevention of Post-dural Puncture Headache Phase 3
Not yet recruiting NCT06272916 - Comparison of the Effect of Aminophylline, Magnesium Sulphate and Placebo in Prevention of Post Dural Puncture Headache in Parturient Undergoing Caesarean Section.
Terminated NCT02827058 - The Influence of Needle Diameter on Post Dural Puncture Headache N/A
Not yet recruiting NCT05262933 - Effects of Preoperative Coffee Consumption in Cesarean Sections Under Spinal Anesthesia
Completed NCT04793490 - Sphenopalatine Ganglion Block for Management of Post- Dural Puncture Headache in Obstetric Patients N/A
Recruiting NCT05888324 - Factors Associated With the Onset of Chronic Headaches in Patients Who Received a Blood Patch in Post Partum
Completed NCT00370604 - Effect of Small Versus Large Epidural Needles on Postdural Puncture Headache Study N/A
Completed NCT04844229 - Bilateral Sphenopalatine Ganglion Block With or Without Bilateral Greater Occipital Nerve Block for Treatment of Obstetric Post-Dural Puncture Headache N/A
Withdrawn NCT03560349 - RCT of SPG Blocks for Post-dural Headache Phase 2
Recruiting NCT06253754 - Pathophysiological Mechanisms and Implication of Treatment in Postural Puncture Headache